This Is Huge News for Novo Nordisk (Hint: It Doesn't Involve Ozempic)
Danish pharmaceutical company Novo Nordisk (NYSE: NVO) is pioneering a new wave of medical treatment for diabetes and obesity ...
Medscape5h
Limited Kidney Benefits With Finerenone in Heart Failure
An analysis of the FINEARTS-HF trial, which showed finerenone's benefits in heart failure outcomes, shows no significant ...
2 Soaring Growth Stocks That Are Still Worth Buying
The company's financial results should remain strong for a while. Analysts expect earnings per share (EPS) to grow at an ...
Reporter.net9h
Two road closures will slow commute around Lebanon
First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof ...
Roche Comes Out Against Allowing Takeover of Drug Manufacturer Catalent
Last week, U.S. consumer groups and labour unions petitioned the U.S. Federal Trade Commission to block Novo Holdings, the ...
Cramer’s week ahead: Earnings from Alphabet, Meta, Apple, Microsoft and Amazon
CNBC's Jim Cramer on Friday urged investors to keep a level head during next week's busy slate of corporate earnings and ...
Eli Lilly (LLY): Dominating the GLP-1 Market with Innovative Treatments
We recently published a list of 10 Best-Performing S&P 500 Stocks in the Last 3 Years. In this article, we are going to take a look at where Eli Lilly (NYSE:LLY) stands against other best performing S ...
Can a popular weight-loss drug reduce risk of Alzheimer’s?
Alzheimer’s causes a gradual decline in memory, thinking, behaviour, and social skills, and it is the most common cause of ...